Full-Time
Senior Learning Experience Designer
Inizio Engage
501-1,000 employees
Provides integrated data insights for pharma
No salary listed
Montreal, QC, Canada + 2 more
More locations: Ontario, Canada | Philadelphia, PA, USA
Hybrid
Must reside in Canada or North America.
 Lab & Research (1) |
|---|
Get referred to Inizio Engage
See people who can refer or advise you
- Experience in Learning Experience Design / Instructional Design
- Understanding of or willingness to learn pharmaceutical and healthcare environments (e.g., pharma sales, MSL engagement, HCP audiences, compliance context)
- Preferably 3+ years of experience translating performance gaps into learning experiences
- Experience building blended learning assets such as in-the-flow-of-work learning assets, AI simulations, PowerPoint decks, facilitator guides, eLearning
- Experience working on projects with deadlines and in a multi-project environment
- Bring fresh thinking and practical use of AI in learning design and solutions
- Must reside in Canada or North America
- Lead instructional design strategy
- Run discovery workshops
- Design blended learning solutions (self-directed, AI-enabled, live workshops - face-to-face and virtual)
- Write learning goals and aligned assessments
- Apply AI thoughtfully within learning solutions
- Develop facilitator and participant materials
- Create eLearning and digital learning assets
- Conduct peer reviews to ensure instructional integrity, learning clarity and optimization for the overall learning experience
- Partner with client stakeholders and internal multidisciplinary teams
- Contribute to the development of proposals in response to an RFP or specific client request
- Challenge and explore different ways we can innovate in learning experience design
- Experience in a life sciences agency or pharmaceutical training agency or similar industry is preferable but not required
Inizio Engage turns scattered data into integrated insights and learning solutions for the pharmaceutical and biotechnology sectors. Its PROPENSITY4 data platform combines data from multiple sources to support decision making across customer needs, commercial operations, and strategic goals. The ecosystem includes Ashfield Excellence Academy, Axiom, Cormis, and Logicearth, which provide training, communications, and capability-building programs for pharma commercial and medical teams. By pairing data analytics with targeted training and talent development, the company helps patients, healthcare professionals, and pharmaceutical firms improve outcomes and gain competitive advantages.
Company Size
501-1,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Upper Dublin Township, Pennsylvania
Founded
N/A
Get referred to Inizio Engage
See people who can refer or advise you
Simplify's Take
What believers are saying
- Ryan Quigley became CEO in 2026, and Jim Sage now leads Inizio Engage.
- July 2026 Connected Insights expands APAC capabilities and AI tools for scientific interactions.
- April 2026 Hub Services strengthens patient access offerings ahead of Asembia 2026 deals.
What critics are saying
- Inizio Group cut redundant roles in 2025; more restructuring hit margins through 2026.
- Revelio shows Inizio Engage job postings fell to 331 in 2026, signaling slower growth.
- Pharma clients can insource patient support and AI workflows, commoditizing Inizio Engage within 24 months.
What makes Inizio Engage unique
- July 2026 Connected Insights turns Medical Information into strategic intelligence for pharma clients.
- April 2026 Hub Services bundles patient access, reimbursement, adherence, and analytics inside one platform.
- Inizio Engage spans 20+ countries and 5 million annual engagements across five specialist areas.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Private Medical Insurance
Life Insurance
Pension Scheme
Hybrid Work Options
Paid Vacation
401(k) Retirement Plan
Company News
Inizio Engage CEO Jim Sage featured in pharmaphorum's "12 Questions" series. Discover Jim Sage's insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum "12 Questions" interview. We're pleased to share that Jim Sage, Global CEO and President of Inizio Engage, has been featured in pharmaphorum's latest "12 Questions" interview series. In the conversation, Jim reflects on his career across international markets, his motivations as a leader, and the experiences that have shaped his approach to building high-performing teams. He also explores some of the most pressing challenges facing the pharmaceutical industry today, including pricing pressures, launch performance, and the need for new reimbursement models. Jim highlights how data, technology, and AI are already transforming the way organisations operate, and discusses the growing importance of patient-centric approaches, from HUB services to personalised support throughout the treatment journey. This content was provided by Inizio Discover Jim Sage's insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum "12 Questions" interview. As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek(R) 2025 in Atlanta, experts from across Inizio reflected... Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making. Inizio today announced the launch of InConcert(TM), a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle. Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders. As the global hematology community prepares for the 67th ASH(R) Annual Meeting and Exposition, Inizio experts share their perspectives on what's driving the field forward - and how pharma companies... At Inizio Medical, we believe AI isn't replacing Medical Affairs - it's redefining what's possible. Our platform, iON.AI(TM), enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless... Discover how Inizio experts are shaping the future of obesity care - where science, strategy, and innovation unite to advance cardiometabolic health and drive real-world impact. At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications and driving real-world impact - discover how this human-centered innovation is defining the... Inizio is leading the way in Intelligent Commercialization(TM) by uniting proprietary AI-powered platforms, deep scientific expertise, and proven governance to unlock measurable, lasting value at every stage of commercialization. * 1 * 2 * 3 * 4 * 5 * 6 * 7 * 8 * 9 * 10 * 11 * 12 * 13 * 14 * 15 * 16 * 17 * 18 * 19 * 20 * 21 * 22 * 23 * 24 * 25 * 26 * 27 * 28 * 29 * 30 * 31 * 32 * 33 * 34 * 35 * 36 * 37 * 38 * 39 * 40 * 41 * 42 * 43 * 44 * 45 * 46 * 47 * 48 * 49 * 50
We're proud to announce that our teams across Inizio Evoke, Inizio Engage, and Inizio Medical have been named finalists in six prestigious categories at the 2025 PM360 Trailblazer Awards, which recognize excellence and innovation in healthcare marketing.
Inizio, a global commercialisation partner to health and life sciences companies, has appointed Ryan Quigley as chief executive.
After a review of potential Patient Support Program (PSP) partners in Italy, Inizio Engage has formed a collaboration with Egg, head quartered in Milan.
Inizio announced that Remco op den Kelder has been appointed to the president of Inizio Advisory and Jim Sage will become president of Inizio Engage.